Literature DB >> 7550340

Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1).

J Ahn1, H J Lüdecke, S Lindow, W A Horton, B Lee, M J Wagner, B Horsthemke, D E Wells.   

Abstract

Hereditary multiple exostoses is an autosomal dominant disorder that is characterized by short stature and multiple, benign bone tumours. In a majority of families, the genetic defect (EXT1) is linked to the Langer-Giedion syndrome chromosomal region in 8q24.1. From this region we have cloned and characterized a cDNA which spans chromosomal breakpoints previously identified in two multiple exostoses patients. Furthermore, the gene harbours frameshift mutations in affected members of two EXT1 families. The cDNA has a coding region of 2,238 bp with no apparent homology to other known gene sequences and thus its function remains elusive. However, recent studies in sporadic and exostosis-derived chondrosarcomas suggest that the 8q24.1-encoded EXT1 gene may have tumour suppressor function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550340     DOI: 10.1038/ng1095-137

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  105 in total

1.  The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis.

Authors:  C Senay; T Lind; K Muguruma; Y Tone; H Kitagawa; K Sugahara; K Lidholt; U Lindahl; M Kusche-Gullberg
Journal:  EMBO Rep       Date:  2000-09       Impact factor: 8.807

2.  The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.

Authors:  C McCormick; G Duncan; K T Goutsos; F Tufaro
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 3.  The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins.

Authors:  G Duncan; C McCormick; F Tufaro
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses.

Authors:  Kazu Matsumoto; Fumitoshi Irie; Susan Mackem; Yu Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

5.  A 4 Mb cryptic deletion associated with inv(8)(q13.1q24.11) in a patient with trichorhinophalangeal syndrome type I.

Authors:  T Sasaki; H Tonoki; H Soejima; N Niikawa
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

Review 6.  Planar cell polarity signaling in craniofacial development.

Authors:  Jacek Topczewski; Rodney M Dale; Barbara E Sisson
Journal:  Organogenesis       Date:  2011-10-01       Impact factor: 2.500

7.  Deletion of 8q24 in an adult with mild dysmorphic features, developmental delay, and ketotic hypoglycemia.

Authors:  Benjamin D Solomon; Eileen Lange; Jay Shubrook; F John Service; Gail Herman; Rajaram J Karne; Phillip Gorden; Maximilian Muenke; Constantine A Stratakis
Journal:  Am J Med Genet A       Date:  2010-06       Impact factor: 2.802

8.  Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.

Authors:  Yvonne M Schrage; Liesbeth Hameetman; Karoly Szuhai; Anne-Marie Cleton-Jansen; Antonie H M Taminiau; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

9.  The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting.

Authors:  Liesbeth Hameetman; Petra Kok; Paul H C Eilers; Anne-Marie Cleton-Jansen; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Virchows Arch       Date:  2005-03-03       Impact factor: 4.064

10.  The type 2 diabetes associated rs7903146 T allele within TCF7L2 is significantly under-represented in Hereditary Multiple Exostoses: insights into pathogenesis.

Authors:  Federica Sgariglia; Elena Pedrini; Jonathan P Bradfield; Tricia R Bhatti; Pio D'Adamo; John P Dormans; Aruni T Gunawardena; Hakon Hakonarson; Jacqueline T Hecht; Luca Sangiorgi; Maurizio Pacifici; Motomi Enomoto-Iwamoto; Struan F A Grant
Journal:  Bone       Date:  2014-12-09       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.